65 related articles for article (PubMed ID: 19582521)
1. Immunohistochemical expression of osteopontin in gastric cancer.
Imano M; Satou T; Itoh T; Sakai K; Ishimaru E; Yasuda A; Peng YF; Shinkai M; Akai F; Yasuda T; Imamoto H; Okuno K; Ito H; Shiozaki H; Ohyanagi H
J Gastrointest Surg; 2009 Sep; 13(9):1577-82. PubMed ID: 19582521
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin promotes gastric cancer progression
Qin YC; Yan X; Yuan XL; Yu WW; Qu FJ
World J Gastrointest Oncol; 2023 Sep; 15(9):1544-1555. PubMed ID: 37746644
[TBL] [Abstract][Full Text] [Related]
3.
Tsai CY; Liao JB; Lee YC; Yang YF
J Cancer; 2023; 14(13):2552-2561. PubMed ID: 37670969
[TBL] [Abstract][Full Text] [Related]
4. Identification of molecular biomarkers for the diagnosis of gastric cancer and lymph-node metastasis.
Seeruttun SR; Cheung WY; Wang W; Fang C; Liu ZM; Li JQ; Wu T; Wang J; Liang C; Zhou ZW
Gastroenterol Rep (Oxf); 2019 Feb; 7(1):57-66. PubMed ID: 30792867
[TBL] [Abstract][Full Text] [Related]
5. Integrated bioinformatics analysis of key genes involved in progress of colon cancer.
Yang H; Wu J; Zhang J; Yang Z; Jin W; Li Y; Jin L; Yin L; Liu H; Wang Z
Mol Genet Genomic Med; 2019 Apr; 7(4):e00588. PubMed ID: 30746900
[TBL] [Abstract][Full Text] [Related]
6. Circulating Levels of Osteopontin Predict Patients' Outcome after Resection of Colorectal Liver Metastases.
Loosen SH; Heise D; Dejong CH; Roy S; Tacke F; Trautwein C; Roderburg C; Luedde T; Neumann UP; Binnebösel M
J Clin Med; 2018 Oct; 7(11):. PubMed ID: 30373147
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional combined biomarkers assay could improve diagnostic accuracy for gastric cancer.
Sun L; Tu H; Chen T; Yuan Q; Liu J; Dong N; Yuan Y
Sci Rep; 2017 Sep; 7(1):11621. PubMed ID: 28912586
[TBL] [Abstract][Full Text] [Related]
8. Immunolocalization of osteopontin in dysplasias and squamous cell carcinomas arising from oral epithelium.
Aravind T; Janardhanan M; Rakesh S; Savithri V; Unnikrishnan UG
J Oral Maxillofac Pathol; 2017; 21(1):18-23. PubMed ID: 28479681
[TBL] [Abstract][Full Text] [Related]
9. Human osteopontin: Potential clinical applications in cancer (Review).
Hao C; Cui Y; Owen S; Li W; Cheng S; Jiang WG
Int J Mol Med; 2017 Jun; 39(6):1327-1337. PubMed ID: 28440483
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling in bladder cancer identifies potential therapeutic targets.
Hussain SA; Palmer DH; Syn WK; Sacco JJ; Greensmith RMD; Elmetwali T; Aachi V; Lloyd BH; Jithesh PV; Arrand J; Barton D; Ansari J; Sibson DR; James ND
Int J Oncol; 2017 Apr; 50(4):1147-1159. PubMed ID: 28259975
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis.
Gu X; Gao XS; Ma M; Qin S; Qi X; Li X; Sun S; Yu H; Wang W; Zhou D
Oncotarget; 2016 Oct; 7(43):69666-69673. PubMed ID: 27626167
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells.
Saleh S; Thompson DE; McConkey J; Murray P; Moorehead RA
BMC Cancer; 2016 Jun; 16():359. PubMed ID: 27282619
[TBL] [Abstract][Full Text] [Related]
13. Gene Expression Profiling of Gastric Cancer.
Marimuthu A; Jacob HK; Jakharia A; Subbannayya Y; Keerthikumar S; Kashyap MK; Goel R; Balakrishnan L; Dwivedi S; Pathare S; Dikshit JB; Maharudraiah J; Singh S; Sameer Kumar GS; Vijayakumar M; Veerendra Kumar KV; Premalatha CS; Tata P; Hariharan R; Roa JC; Prasad TS; Chaerkady R; Kumar RV; Pandey A
J Proteomics Bioinform; 2011 Apr; 4(4):74-82. PubMed ID: 27030788
[TBL] [Abstract][Full Text] [Related]
14. Correlation between calcification and bone sialoprotein and osteopontin in papillary thyroid carcinoma.
Wu G; Guo JJ; Ma ZY; Wang J; Zhou ZW; Wang Y
Int J Clin Exp Pathol; 2015; 8(2):2010-7. PubMed ID: 25973097
[TBL] [Abstract][Full Text] [Related]
15. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS
BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer.
Di Bartolomeo M; Pietrantonio F; Pellegrinelli A; Martinetti A; Mariani L; Daidone MG; Bajetta E; Pelosi G; de Braud F; Floriani I; Miceli R
Gastric Cancer; 2016 Apr; 19(2):412-420. PubMed ID: 25862567
[TBL] [Abstract][Full Text] [Related]
17. Serum OPN expression for identification of gastric cancer and atrophic gastritis and its influencing factors.
Chen T; Sun L; He C; Gong Y; Xu Q; Yuan Y
PLoS One; 2014; 9(12):e114005. PubMed ID: 25479069
[TBL] [Abstract][Full Text] [Related]
18. Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.
Qiu Y; Hu Y; Zhang ZY; Ye L; Xu FH; Schneider ME; Ma XL; Du YX; Zuo XB; Zhou FS; Chen G; Xie XS; Zhang Y; Xia HZ; Wu JF; Du WD
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2143-56. PubMed ID: 25009318
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer.
Abe H; Hino R; Fukayama M
Virchows Arch; 2013 May; 462(5):523-31. PubMed ID: 23536282
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.
Cao DX; Li ZJ; Jiang XO; Lum YL; Khin E; Lee NP; Wu GH; Luk JM
World J Gastroenterol; 2012 Aug; 18(30):3923-30. PubMed ID: 22912540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
